,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'destiny-breast04']
the results of destiny-breast04 published in #asco22
Narjust Duma, MD, (@NarjustDumaMD) #LCSM Oncologist from @DanaFarber, takes over our Twitter today to discuss #ASCO22.